JPRN-UMIN000006799Completed未知
Comparison of DPP-4 inhibitor, sitagliptin and nateglinide, and liraglutide and exenatide in type 2 diabetes: a CGM based-study - Comparison of DPP-4 inhibitor, sitagliptin and nateglinide, and liraglutide and exenatide
Yokohama City University Medical Center0 sites80 target enrollmentStarted: December 5, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)severe ketosis, diabetic coma within 6 months 2)severe infection, before operation, severe trauma 3)severe hepatic dysfunction 4)or severe renal dysfunction (eGFR: more than 1.5mg/dl) 5)Patients who use of insulin 6)pregnacy 7)Allergy for sitagliptin, nateglinide,liraglutide and exenatide 8)Patients judged by the investigator to be ineligible for some other reason
Investigators
Similar Trials
Completed
Not Applicable
Comparison of DPP-4 inhibitors, vildagliptin and linagliptin in type2 diabetesType 2 diabetes mellitusJPRN-UMIN000010445Yokohama City University Medical Center100
Completed
Not Applicable
Effects of DPP4 inhibitor, sitagliptin or Sulfonylurea on intrahepatic adipose mass and lipid metabolism in patients with type 2 diabetes accompanied by fatty liver : a prospective randomized, open-label trialType 2 diabetesJPRN-UMIN000013356St.Marianna University School of Medicine60
Unknown
Phase 4
Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic ClampType 2 DiabetesNCT02386943Shanghai Jiao Tong University School of Medicine12
Unknown
Phase 4
Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"Type 2 DiabetesNCT01660386Shanghai Jiao Tong University School of Medicine12
Completed
Phase 4
Comparison of DPP-4 Inhibitors versus Dapagliflozin in combination with insulin using continuous glucose monitoring in patients with type 2 diabetes mellitus -prospective randomized controlled trialtype 2 diabetes mellitusJPRN-UMIN000015033Hokkaido University Hospital36